Bacopa Monnieri Reduces Neurodegenerative Biomarkers and Improves Cognitive Function

The Study

Valotto Neto, a researcher from the Department of Biochemistry and Pharmacology, led a systematic review on the therapeutic applications of Bacopa monnieri (BM) in neurodegenerative conditions. The review included 22 clinical trials, which demonstrated BM's potential benefits for brain health. The researchers analyzed the effects of BM on various cognitive functions, emotional well-being, and biomarkers of neurodegeneration.

What They Measured and What They Found

The review found that BM supplementation reduced Nuclear Factor-κB phosphorylation, improved emotional function, cognitive functions, anhedonia, hyperactivity, sleep routine, depression, attention deficit, learning problems, memory retention, impulsivity, and psychiatric problems. Additionally, BM decreased the levels of pro-inflammatory biomarkers and oxidative stress. The primary outcome variables measured included cognitive functions, emotional function, and biomarkers of neurodegeneration.

The Mechanism: Why It Works

Bacopa monnieri's active compounds, such as bacosides A and B, betulinic acid, loliolide, asiatic acid, and quercetin, contribute to its anti-apoptotic and antioxidant actions. These compounds can repair damaged neurons, stimulate kinase activity, restore synaptic function, improve nerve transmission, and increase neuroprotection. The anti-apoptotic actions of BM may be related to its ability to reduce Nuclear Factor-κB phosphorylation, which is a key regulator of inflammation and cell death.

Practical Application Protocol

Based on the review's findings, a potential protocol for using Bacopa monnieri to support cognitive function and reduce neurodegenerative biomarkers could be:

• Consume 300-400 mg of Bacopa monnieri extract per day, standardized to contain 20-30% bacosides


• Divide the daily dose into 2-3 administrations, taken with meals to enhance absorption


• Combine with other neuroprotective compounds, such as omega-3 fatty acids, vitamins D and B12, and magnesium, to potentiate the effects


• Monitor cognitive function, emotional well-being, and biomarkers of neurodegeneration regularly to adjust the protocol as needed

Study Limitations

While the review provides valuable insights into the therapeutic potential of Bacopa monnieri, there are some limitations to consider. The sample size of the included clinical trials was not explicitly stated, which may affect the generalizability of the findings. Additionally, the review focused on the therapeutic applications of BM in neurodegenerative conditions, but did not investigate its effects on other health outcomes. Further research is needed to fully understand the mechanisms of action and potential benefits of Bacopa monnieri.

Disclaimer: This article is for informational and educational purposes only. The information presented does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before modifying your diet, supplementation, or exercise routines. The scientific studies cited reflect the state of knowledge at their publication date and may be subject to revision.